CN116376913A - miRNA and application thereof in rice insecticidal improvement - Google Patents
miRNA and application thereof in rice insecticidal improvement Download PDFInfo
- Publication number
- CN116376913A CN116376913A CN202310170244.3A CN202310170244A CN116376913A CN 116376913 A CN116376913 A CN 116376913A CN 202310170244 A CN202310170244 A CN 202310170244A CN 116376913 A CN116376913 A CN 116376913A
- Authority
- CN
- China
- Prior art keywords
- mirna
- rice
- mir
- transgenic
- plant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002679 microRNA Substances 0.000 title claims abstract description 60
- 235000007164 Oryza sativa Nutrition 0.000 title claims abstract description 53
- 235000009566 rice Nutrition 0.000 title claims abstract description 53
- 108091070501 miRNA Proteins 0.000 title claims abstract description 21
- 230000006872 improvement Effects 0.000 title abstract description 8
- 230000000749 insecticidal effect Effects 0.000 title abstract description 6
- 240000007594 Oryza sativa Species 0.000 title 1
- 241000209094 Oryza Species 0.000 claims abstract description 62
- 241000426497 Chilo suppressalis Species 0.000 claims abstract description 29
- 241000196324 Embryophyta Species 0.000 claims abstract description 28
- 241000238631 Hexapoda Species 0.000 claims abstract description 23
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 14
- 238000011161 development Methods 0.000 claims abstract description 9
- 230000001404 mediated effect Effects 0.000 claims abstract description 9
- 239000002773 nucleotide Substances 0.000 claims abstract description 6
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 claims abstract description 5
- 150000007523 nucleic acids Chemical group 0.000 claims abstract description 4
- 230000009261 transgenic effect Effects 0.000 claims description 41
- 230000014509 gene expression Effects 0.000 claims description 30
- 238000000034 method Methods 0.000 claims description 25
- 230000034994 death Effects 0.000 claims description 13
- 239000013598 vector Substances 0.000 claims description 8
- 238000000338 in vitro Methods 0.000 claims description 6
- 230000006378 damage Effects 0.000 claims description 5
- 239000013604 expression vector Substances 0.000 claims description 5
- 230000030279 gene silencing Effects 0.000 claims description 5
- 230000009466 transformation Effects 0.000 claims description 5
- 241000589158 Agrobacterium Species 0.000 claims description 4
- 238000012226 gene silencing method Methods 0.000 claims description 4
- 230000002147 killing effect Effects 0.000 claims description 2
- 230000001131 transforming effect Effects 0.000 claims description 2
- 239000002917 insecticide Substances 0.000 claims 2
- 108091046501 miR-1579 stem-loop Proteins 0.000 abstract description 43
- 108090000623 proteins and genes Proteins 0.000 abstract description 12
- 230000001276 controlling effect Effects 0.000 abstract description 7
- 230000009368 gene silencing by RNA Effects 0.000 abstract description 7
- 238000011160 research Methods 0.000 abstract description 7
- 238000010353 genetic engineering Methods 0.000 abstract description 3
- 230000035790 physiological processes and functions Effects 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 231100000518 lethal Toxicity 0.000 abstract description 2
- 230000001665 lethal effect Effects 0.000 abstract description 2
- 108091030071 RNAI Proteins 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 108700011259 MicroRNAs Proteins 0.000 description 43
- 101100510416 Drosophila melanogaster Kr-h1 gene Proteins 0.000 description 32
- 238000006243 chemical reaction Methods 0.000 description 25
- 239000013612 plasmid Substances 0.000 description 23
- 239000006228 supernatant Substances 0.000 description 15
- 239000000047 product Substances 0.000 description 14
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 13
- 238000011529 RT qPCR Methods 0.000 description 13
- 238000005406 washing Methods 0.000 description 11
- 238000004166 bioassay Methods 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 108091032955 Bacterial small RNA Proteins 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000002299 complementary DNA Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- 108091026821 Artificial microRNA Proteins 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 108060001084 Luciferase Proteins 0.000 description 7
- 239000005089 Luciferase Substances 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 7
- 239000002609 medium Substances 0.000 description 7
- 239000000243 solution Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 6
- 239000011324 bead Substances 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000001114 immunoprecipitation Methods 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000001727 in vivo Methods 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 239000000523 sample Substances 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 108091092584 GDNA Proteins 0.000 description 4
- 238000012228 RNA interference-mediated gene silencing Methods 0.000 description 4
- 239000000556 agonist Substances 0.000 description 4
- 230000027455 binding Effects 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 210000002468 fat body Anatomy 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 230000002829 reductive effect Effects 0.000 description 4
- 238000010839 reverse transcription Methods 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 241000353522 Earias insulana Species 0.000 description 3
- 241000746966 Zizania Species 0.000 description 3
- 235000002636 Zizania aquatica Nutrition 0.000 description 3
- 230000009418 agronomic effect Effects 0.000 description 3
- 238000003766 bioinformatics method Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000001962 electrophoresis Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 238000001502 gel electrophoresis Methods 0.000 description 3
- 238000000227 grinding Methods 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000035772 mutation Effects 0.000 description 3
- 230000033458 reproduction Effects 0.000 description 3
- 238000012216 screening Methods 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 238000001890 transfection Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 2
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 2
- 108020005345 3' Untranslated Regions Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 2
- 102000012410 DNA Ligases Human genes 0.000 description 2
- 108010061982 DNA Ligases Proteins 0.000 description 2
- LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 2
- 101100532034 Drosophila melanogaster RTase gene Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 108090000331 Firefly luciferases Proteins 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 101710124239 Poly(A) polymerase Proteins 0.000 description 2
- 241000382353 Pupa Species 0.000 description 2
- 108091034057 RNA (poly(A)) Proteins 0.000 description 2
- 108010052090 Renilla Luciferases Proteins 0.000 description 2
- 102000006382 Ribonucleases Human genes 0.000 description 2
- 108010083644 Ribonucleases Proteins 0.000 description 2
- 238000012167 Small RNA sequencing Methods 0.000 description 2
- 241000176086 Sogatella furcifera Species 0.000 description 2
- 239000005557 antagonist Substances 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 238000000749 co-immunoprecipitation Methods 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 2
- 229960005156 digoxin Drugs 0.000 description 2
- LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 238000001976 enzyme digestion Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 108091046293 miR-1902 stem-loop Proteins 0.000 description 2
- 108091053942 miR-2965 stem-loop Proteins 0.000 description 2
- 108091047220 miR-3715 stem-loop Proteins 0.000 description 2
- 108091060293 miR-453 stem-loop Proteins 0.000 description 2
- 108091028552 miR-7044 stem-loop Proteins 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000002018 overexpression Effects 0.000 description 2
- 239000000575 pesticide Substances 0.000 description 2
- 230000001124 posttranscriptional effect Effects 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 238000012163 sequencing technique Methods 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000000451 tissue damage Effects 0.000 description 2
- 231100000827 tissue damage Toxicity 0.000 description 2
- 238000003151 transfection method Methods 0.000 description 2
- 239000012096 transfection reagent Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 241000219194 Arabidopsis Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 241001498622 Cixius wagneri Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 230000007018 DNA scission Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 108010042407 Endonucleases Proteins 0.000 description 1
- 102000004533 Endonucleases Human genes 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241001466042 Fulgoromorpha Species 0.000 description 1
- 102000003960 Ligases Human genes 0.000 description 1
- 108090000364 Ligases Proteins 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 241000196322 Marchantia Species 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000819999 Nymphes Species 0.000 description 1
- 238000010222 PCR analysis Methods 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 230000004570 RNA-binding Effects 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- 238000002105 Southern blotting Methods 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 230000024245 cell differentiation Effects 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 238000012165 high-throughput sequencing Methods 0.000 description 1
- 101150047832 hpt gene Proteins 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000001418 larval effect Effects 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 238000003670 luciferase enzyme activity assay Methods 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 230000005868 ontogenesis Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000008654 plant damage Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000022532 regulation of transcription, DNA-dependent Effects 0.000 description 1
- 238000004153 renaturation Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000030118 somatic embryogenesis Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- 230000009752 translational inhibition Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N57/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds
- A01N57/10—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds
- A01N57/16—Biocides, pest repellants or attractants, or plant growth regulators containing organic phosphorus compounds having phosphorus-to-oxygen bonds or phosphorus-to-sulfur bonds containing heterocyclic radicals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P7/00—Arthropodicides
- A01P7/04—Insecticides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
- C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
- C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
- C12N15/8286—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for insect resistance
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
- C12N2310/141—MicroRNAs, miRNAs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/10—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
- Y02A40/146—Genetically Modified [GMO] plants, e.g. transgenic plants
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Environmental Sciences (AREA)
- Insects & Arthropods (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cell Biology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention belongs to the technical field of plant genetic engineering. In particular to miRNA and application thereof in rice insecticidal improvement. The nucleotide sequence of the miRNA is shown as SEQ ID NO. 1 or is obtained by modifying, substituting, deleting or adding at least one base into the nucleic acid sequence shown as SEQ ID NO. 1. The miRNA designed and synthesized by the invention, namely miR-1579, has the function of regulating and controlling reproduction and development of the chilo suppressalis, is lethal to the chilo suppressalis, and provides an effective product for preventing and controlling the chilo suppressalis; the prepared RNAi mediated novel insect-resistant crop is environment-friendly, can accurately target genes to regulate and control the physiological process of insects, and has low potential risk. The miRNA designed and synthesized by the invention provides a new research thought for prevention and control of crops, especially rice pests, and has high research value and wide application prospect.
Description
Technical Field
The invention belongs to the technical field of plant genetic engineering. In particular to an miRNA and application thereof in rice insecticidal improvement. A chilo suppressalis miRNA sequence is obtained through cloning, and the function of the sequence is verified, so that the miRNA sequence can be proved to be used for rice insecticidal improvement.
Background
Plant-mediated RNA silencing is a posttranscriptional double-stranded RNA (dsRNA) -mediated gene silencing mechanism and has proven to be an effective and environmentally-friendly alternative method for pest control. microRNA (miRNA) is a non-coding RNA with a length of about 21-28 nt, which can trigger a corresponding RNA interference (RNAi) pathway to participate in various physiological processes such as development, reproduction and apoptosis of organisms. By using a natural plant miRNA precursor as a framework, a sequence of 21nt which is designed artificially and aims at a target gene is substituted for a corresponding natural miRNA sequence, and mature artificial miRNA (artificial microRNA, amiRNA) can be generated according to a biological formation mechanism of the natural miRNA. amiRNA can then silence the expression of the target gene as specifically as the natural miRNA.
Currently, amiRNA technology has been successfully applied to the specific inhibition of expression of endogenous or exogenous genes in a variety of plants such as Arabidopsis, tobacco, tomato, rice, moss, and algae (Niu et al 2006; schwabet et al 2006; qu et al 2007; khraiwish et al 2008; warthmann et al 2008; molnar et al 2009). amiRNA interference has higher specificity compared with dsRNA interference, is not easy to cause the phenomenon of off-target, and is known as a second generation gene silencing technology (Tang et al 2007). At present, the technology is widely applied to the fields of functional genome research, variety improvement and medical treatment.
The prior art CN 107663522B relates to a method for cultivating insect-resistant rice by using Chilo suppressalis small RNA. Functional verification and application research are carried out on the obtained Chilo suppressalis [ Chilo suppressalis (Walker) endogenous small RNA sequence, a nucleotide sequence of the Chilo suppressalis endogenous small RNA csu-53 is obtained by utilizing high-flux small RNA sequencing and bioinformatics analysis, an artificial microRNA (amiRNA) expression vector is constructed by utilizing the sequence of the csu-53, and rice is transformed, and an in-vitro stem grafting experiment shows that the transgenic rice can obviously prolong the growth cycle of Chilo suppressalis larvae on rice plants and reduce the insect weight and pupae weight. The rice stem borer endogenous small RNA isolated by the invention can be applied to rice pest resistance improvement, in particular to application in inhibiting rice pest stem borer growth.
The invention belongs to the technical field of plant genetic engineering and relates to the prior art CN 104673827A. In particular to application of Chilo suppressalis [ Chilo suppressalis (Walker) ] endogenous small RNA in rice insect-resistant improvement. The invention performs functional verification and application research on the obtained Chilo suppressalis endogenous small RNA sequence. And obtaining the DNA sequence of the stem borer endogenous small RNA csu-15 by utilizing a high-throughput small RNA sequencing and bioinformatics analysis method.
However, the two patents show that the transgenic rice can only reduce the weight of larvae and inhibit the growth of the Chilo suppressalis larvae through an in vitro stalk insect-grafting test, and has a certain insect-resistant effect, but cannot kill insects.
Disclosure of Invention
The invention aims at providing miRNA, the nucleotide sequence of which is shown as SEQ ID NO. 1 or the nucleic acid sequence shown as SEQ ID NO. 1 is modified, substituted, deleted or added with at least one base to obtain the nucleic acid sequence.
SEQ ID NO:1:CGUGGCGGGAAGCGGAUGCGGCC。
Preferably, the modification comprises cholesterol and/or four thio-skeleton modified full-chain methoxy modifications at the 3 'end of the nucleotide shown in SEQ ID NO. 1, and two thio-skeleton modifications at the 5' end.
The second object of the present invention is to provide a kit, recombinant vector or transgenic cell comprising the above miRNA.
The invention also aims to provide the application of the miRNA or the kit, the recombinant vector or the transgenic cell in insect control, wherein the application is the killing of insect bodies.
Preferably, the insect is a rice pest.
Further preferably, the rice pest is Chilo suppressalis.
The fourth object of the invention is to provide the application of the miRNA or the kit, the recombinant vector or the transgenic cell in preparing pesticides.
The invention also provides a pesticide containing the miRNA or the kit, the recombinant vector or the transgenic cell.
The sixth object of the present invention is to provide an insect control method comprising the steps of: allowing the plant body to express the miRNA.
Preferably, the plant is rice.
Preferably, the insect control method comprises the steps of:
s1, constructing a miRNA expression cassette for mediating gene silencing in vitro by using the miRNA; and transforming the constructed final expression vector into rice through agrobacterium-mediated transformation to obtain a transgenic rice plant.
S2, cutting fresh stems of the obtained transgenic rice plants into stem segments, feeding the stem segments to newly hatched 1-year-old larvae, placing the larvae in a culture dish until death, and recording the death rate and the individual development condition;
or taking a plurality of first 1-year larvae to be connected to transgenic rice plants, placing the transgenic rice plants in a pest cage until death, and recording the death rate and the damage condition of the plants.
Preferably, the number of the heads is 10-30.
MiRNAs are mainly involved in life processes such as ontogenesis, cell differentiation, apoptosis and proliferation of organisms at posttranscriptional level through three modes of transcriptional regulation, transcriptional inhibition and translational inhibition. Because of their important role in insect development, inhibition of expression and overexpression of mirnas may both affect normal development of the organism. Direct knockout of mirnas is not well achieved due to the limitations in miRNA size. Studies of miRNA function are mainly identified by enhancing or attenuating expression of the miRNA of interest. The most widely used is to chemically synthesize miRNA antagonists (miRNA antagomir) and miRNA agonists (miRNA agomir) by using specific miRNAs sequences, and compared with common miRNA inhibitors (miRNA inhibitors) and miRNA mimics (miRNA mini), the miRNA antagonists (miRNA inhibitors) and miRNA mimics (miRNA mini) have stronger cell affinity, stability and inhibition. By introducing miRNA into the organism, the expression of the target gene in the organism is enhanced or weakened, so that the normal growth and development process of the organism is influenced. Especially those target genes for preventing and controlling pests have strong pertinence and lethality to rice pests after silencing, and the genes can be used as ideal candidate gene resources for creating novel RNAi-mediated insecticidal crops.
The miRNA designed and synthesized by the invention, namely miR-1579, has the function of regulating and controlling reproduction and development of the chilo suppressalis, is lethal to the chilo suppressalis, and provides an effective product for preventing and controlling the chilo suppressalis; the prepared RNAi mediated novel insect-resistant crop is environment-friendly, can accurately target genes to regulate and control the physiological process of insects, and has low potential risk. Provides a new research thought for preventing and controlling crop pests, especially rice pests, and has high research value and wide application prospect.
Drawings
FIG. 1 is a Vg expression profile;
FIG. 2 shows in vitro and in vivo experiments to demonstrate that miR-1579 directly targets Kr-h1;
FIG. 3 shows that overexpression of miR-1579 resulted in high mortality of Chilo suppressalis larvae;
FIG. 4 is a molecular characterization of transgenic rice;
FIG. 5 shows the bioassay of Chilo suppressalis on transgenic rice;
FIG. 6 is a safety evaluation of transgenic rice against non-target insects;
FIG. 7 is an agronomic trait evaluation of transgenic rice.
Detailed Description
Example 1 acquisition of miR-1579
1. Bioinformatics analysis miR-1579 targeting Kr-h1
Since Vg is a gene encoding a major vitellin precursor (YPP), it is commonly used to monitor the physiological phase of vitelline genesis. The expression level of Vg was detected by qPCR method as follows:
a qPCR reaction was performed using specific primers for Vg (Cs-Vg-F: GGCTCGCTTGGAGAAGCCTA (SEQ ID NO: 2); cs-Vg-R: GCCACCTTCTACGGCGATCT (SEQ ID NO: 3)) in combination with a qPCR kit (Takara) in the following system:
TB Green Premix Ex TaqII:5μL
Cs-Vg-F:0.4μL
Cs-Vg-R:0.4μL
a DNA template: 2 mu L
Sterilizing water: 2.2 mu L
The reaction conditions are as follows: 95 ℃ for 30s;95 ℃ for 5 seconds, 60 ℃ for 30 seconds, 40cycles; dissolution profile: 95℃ 5s,60℃1min,95℃ 15s,1 cycle.
The results showed that the expression level of Vg was in an upward trend in the female pupa fat bodies of 1 to 7 days old and was sharply increased on day 4 (see fig. 1), which laterally indicated that the pupal stage was a key period for the vitelline occurrence of chilo suppressalis.
Thus, the fat body on day 4 of the selection of female pupae was sent to Hua big gene (Shenzhen) for high throughput sequencing to obtain small RNA library. Early experiments found that transcription factor Kr-h1 was able to regulate vitelline formation in female pupae (Tang et al 2020), we predicted MiRNAs in the small RNA pool that were likely to target Kr-h1 using three software, miRanda v3.3a, targetScan v7.0, and RNAhybrid 2.1.2. A total of 10 miRNAs were predicted to bind Kr-h1, respectively: miR-6475-5p, miR-1902, miR-7044-5p, miR-3715, miR-453, miR-2965, novel-miR-77, novel-miR-41 and miR-1579 bind to the CDS region of Kr-h1, and novel-miR-23 binds to the 3' UTR of Kr-h1.
2. In vitro and in vivo experiments prove that miR-1579 targets Kr-h1
1) Intracellular validation: the CDS and 3' UTR of Kr-h1 were inserted into psiCHECK-2 plasmid to obtain recombinant plasmid, and the predicted mimics of 10 miRNAs were synthesized by Ruibo biological Co., guangzhou, and the recombinant plasmid was co-transfected with 10 miRNAs into HEK293T cells, respectively, and analyzed for luciferase activity.
The method for constructing the recombinant plasmid is as follows:
linearisation of psicheck-2 plasmid: the circular plasmid was linearized with XhoI and MssI endonucleases (Thermo Fisher) in the system: 10X FastDigest Green buffer:2 mu L
psiCHECK-2 plasmid: 1 μg
XhoI:1μL
MssI:1μL
Supplement DEPC H 2 O to 20. Mu.L
Reaction conditions: 30min at 37 ℃;80 ℃ for 5min. And (3) performing gel electrophoresis after the reaction is finished, and cutting gel and recovering to obtain the purified psiCHECK-2 linearized plasmid.
B, double enzyme digestion of PCR products: firstly, designing a primer (Cs-Kr-h 1-F: ACTCTTATACCCCACTCCCCC (SEQ ID NO: 4) according to a Kr-h1 sequence and an enzyme cutting site, wherein the primer is Cs-Kr-h1-R:
GGGTTTTTAAGAGAAGTGCATGGAT(SEQ ID NO:5))
the primer (the engineering) is synthesized, and the PCR reaction is carried out according to the specification by combining high-fidelity enzyme PrimeSTAR Max Premix (2X) (Takara), wherein the PCR reaction system is as follows:
PrimeSTAR Max Premix(2X):5μL
Cs-Kr-h1-F:1μL
Cs-Kr-h1-R:1μL
Template:1μL
sterilizing water: make up to 10 mu L
The reaction conditions are as follows: 98 ℃ for 5min;98℃for 10s,54-60℃for 15s,72℃for 1min for 30s;2-4 steps of reaction for 30cycles; and at 72℃for 10min.
And (3) gel electrophoresis, gel cutting and recovery to obtain a PCR product of Kr-h1, and then double enzyme cutting is carried out on the PCR product, wherein an enzyme cutting system is as follows: PCR product: 0.2. Mu.g, the remainder being the same as the system and reaction conditions for linearization of the psiCHECK-2 plasmid described above. And (3) performing gel electrophoresis after the reaction is finished, and cutting gel and recovering to obtain a purified Kr-h1 double enzyme cutting product.
C. And (3) connection: the PCR product and psiCHECK-2 plasmid linearization product were ligated using T4 ligase (NEB) in the following system:
T4 DNA Ligase:1μL
T4 DNA Ligase Buffer(10X):2μL
PCR product and psiCHECK-2 linearized plasmid: the molar ratio is 3:1 add in
Nuclease-free water to 10. Mu.L
Overnight connection at 16℃and 15min at 65 ℃. Then it is transformed into competent cell Trans1-T1, sequencing (engineering) to determine the correctness of the insert, and obtaining psiCHECK-2+Kr-h1 recombinant plasmid.
Hek293t cell culture:
incomplete medium: dulbecco's Modified Eagle's Medium (Gibco)
Preparing a complete culture medium: incomplete culture medium+10% fetal bovine serum (Gibco) +1% green streptomycin mixed solution
A T25 flask was charged with 4mL complete medium containing 5% CO at 37 ℃ 2 Culturing in an incubator.
E. The cell transfection method is as follows:
cells were seeded into 24-well cell culture plates and cell transfection was performed at a cell confluence of approximately 80%.
a. Diluting the miRNA mimic to a final concentration of 50nM;
b. dilution transfection reagent Lipofectamine TM 3000 (invitrogen) 1.5. Mu.L Lipofectamine per well in 25. Mu.L of incomplete medium TM Diluting at 3000, and incubating for 5min at room temperature;
c. the incomplete medium diluted psiCHECK-2+kr-h1 recombinant plasmid, per well plasmid: the ratio of transfection reagents was 1:1.5, incubating for 5min at room temperature;
d. mixing the diluted solutions a, b and c to prepare a mixed solution, and incubating for 15min at room temperature;
e. removing old complete medium in the culture plate, adding 200 μl of complete medium without double antibody (complete medium without 1% of mixture of penicillin and streptomycin), and adding the mixture, and adding CO at 37deg.C 2 Culturing in an incubator for 24 hours;
f. the dual luciferase reporter kit (Promega) detects luciferase activity as follows:
all media in 24 well plates after transfection was discarded, washed once with 200 μl PBS, and lysed cells with 100 μl 1X Passive Lysis Buffer; placing on a shaking table, shaking at room temperature for 15-20min; 10 mu L of lysate is taken and added into an ELISA plate, 50 mu L Luciferase Assay Reagent II is added, a multifunctional ELISA (Tecan) is used for detecting the activity of firefly luciferase, 50 mu L of Stop & Glo Reagent is added, the activity of Renilla luciferase is detected, and the ratio of firefly luciferase to Renilla luciferase is calculated.
The result shows that: after transfection, the luciferase activities of miR-3715, miR-453, miR-1902, miR-2965, novel-miR-41, novel-miR-23 or miR-6475-5p were unchanged, and the luciferase activities of miR-7044-5p and novel-miR-77 were up-regulated by 1.63 times and 1.7 times respectively, while the luciferase reporter activities of miR-1579 were significantly reduced (see FIG. 2 a), indicating that miR-1579 down-regulates Kr-h1.
Subsequently, the "seed region" of the mutant miR-1579 and Kr-h1 binding site, method reference to the mutant binding site (Chiu et al 2004) designed a mutant primer:
miR-1579-Rt:GGGGGAGTGGGGTATAAGAGT(SEQ ID NO:6)
miR-1579-Ft:GGGAAGCTTCACGCGGTACCAAGGATCCACACTGGCGAAAGAC(SEQ ID NO:7)
miR-1579-Rs:TCCTTGGTACCGCGTGAAGCTTCCCAGAGTGTTCAAAGGCCG(SEQ ID NO:8)
miR-1579-Fs:ATCCATGCACTTCTCTTAAAAACCC(SEQ ID NO:9)。
the detailed steps of mutating the binding site are:
first, psiCHECK-2+kr-h1 recombinant plasmid was used as a template, and diluted to 100-300 pg/. Mu.l, usingHS DNA Polymerase with GC Buffer (Takara) was subjected to PCR reaction in the following reaction system:
5×Prime STAR HS Buffer/2×GCbuffer:10μl/25μL
dNTPs(2.5mM):4μL
miR-1579-Ft/Fs/Rt/Rs (10. Mu.M): 2 mu L each
Plasmid template: 2 mu L
Polymerase: 0.5 mu L
Sterilizing water: make up to 50 mu L
The reaction procedure: 98 ℃ for 10s,55 ℃ for 15s and 72 ℃ for 7min, 29cycles and 72 ℃ for 15min are carried out in three steps; and detecting the PCR product by agarose gel electrophoresis, and cutting gel and recovering to obtain the full length of the plasmid. Then the obtained plasmid is digested with restriction enzyme DpnI (Thermo Fisher), and the digestion system is as follows:
1X FastDigest Buffer:2μL
plasmid: 500ng
DpnI:1μL
Nuclease-free water to 20. Mu.L
Incubating for 1h at 37 ℃; subsequent denaturation and renaturation. The procedure was followed at 99℃for 3min;65 ℃ for 5min; 15min at 30 ℃, and the last two steps are circulated twice; and directly converting the obtained product, picking clone, sequencing, and verifying mutation result. The mutant plasmid and miR-1579 mimetic were transfected into cells according to the cell transfection method (which was identical to the procedure described in examples 1-2-1E except that the recombinant plasmid was replaced with the mutant plasmid). As a result, the inhibition of miR-1579 on Kr-h1 luciferase activity is remarkably eliminated after mutation (see FIG. 2 b), which shows that the mutation site is a real binding site of miR-1579 and Kr-h1.
2) In vivo miR-1579 and Kr-h1 expression levels are inversely related: the RNA of the head, ovary and fat body of the 1-7d female pupae and the 4 th day female pupae were extracted according to RNAiso Plus reagent Specification (Takara), the extraction steps were as follows:
grinding the sample by a grinding rod, continuously adding liquid nitrogen until the sample is ground into powder, adding 1mL of RNAiso Plus to form a homogenate, and standing at room temperature for 5min; centrifuging at 12000 Xg and 4 ℃ for 5min; carefully aspirate the supernatant and transfer into a new centrifuge tube; adding 200 mu L of chloroform, shaking and mixing until the solution is emulsified to be milky white; standing at room temperature for 5min; centrifuging at 12000 Xg and 4 ℃ for 15min; sucking colorless supernatant and transferring the supernatant to another new centrifuge tube; adding isopropanol with the volume of 0.5-1 times of RNAiso Plus into the supernatant, reversing the centrifuge tube upside down, fully and uniformly mixing, and standing for 10min at room temperature; centrifuging at 12000 Xg and 4 ℃ for 10min; the supernatant was discarded, 1mL of 75% ethanol was added, the tube wall of the centrifuge tube was gently washed upside down, and after centrifugation at 7500 Xg at 4℃for 5min, the supernatant was carefully discarded; washing once again with 1mL of 75% ethanol; discarding the supernatant, opening a centrifugal tube cover, and drying and precipitating for a few minutes at room temperature; the precipitate was dissolved by adding 20-50. Mu.L of RNase-free water to obtain RNA. The obtained RNA is used for respectively detecting the expression quantity of miR-1579 and Kr-h1, and the specific steps are as follows:
A. detection of the spatiotemporal and tissue expression of Kr-h 1: by PrimeScript TM RT reagent Kit with gDNA Eraser (Perfect Real Time) kit reverse transcribes RNA into cDNA, and reverse transcription is performed as follows:
A1. the system for removing the genomic DNA reaction is as follows:
5×gDNA Eraser Buffer:2μL
gDNA Eraser:1μL
Total RNA:1μg
RNase Free dH2O: supplement to 10. Mu.L
42 ℃ for 2min; immediately placing on ice;
A2. the reverse transcription reaction is then carried out, and the reverse transcription system is as follows:
reaction solution after removing genomic DNA reaction: 10 mu L
PrimeScript RT Enzyme Mix I:1μL
RT Primer Mix:1μL
5×PrimeScript Buffer 2(for Real Time):4μL
RNase Free dH 2 O:4μL
The cDNA was stored for a short period of time at 37℃for 15min,85℃for 5s, and 4℃for a long period of time at-20 ℃.
A3. The obtained cDNA was used for qPCR analysis of the space-time and tissue expression of Kr-h1, the qPCR method was identical to that in example 1-1, and Kr-h1 specific primers were: cs-Kr-h1-F: ATGGCGAACGTTGTTACCGC (SEQ ID NO: 10); cs-Kr-h1-R: GAGTTTCCGCACCGTGTTCC (SEQ ID NO: 11);
B. detecting the space-time expression and the tissue expression of miR-1579: and (3) designing and synthesizing miR-1579 specific qPCR primers in the Ruibo organism (Guangzhou), and detecting the expression quantity by adopting a miRNA tailing method. According to MIDETECT A Track TM The miRNA qRT-PCR Starter kit (Ruibo) instruction book detects the expression level of miR-1579, and the specific steps for detecting the expression level of miRNA by a tail addition method are as follows:
poly (A) carrying out a carrying out reaction, wherein the system is as follows:
Total RNA:1μg
5×Poly(A)Polymerase Buffe:2μL
Poly(A)Polymerase:1μL
RNase-free water:up to 10μL
placing the mixture on ice for standby after the reaction is finished at 37 ℃ for 1h;
then reverse transcription reaction is carried out, and the system is as follows:
RTase mix:4μL
5×RTase Buffer:4μL
miDETECT A TrackTM Uni-RT Primer:2μL
poly (A) training product: 10 mu L
42 ℃ for 1h at 72 ℃ for 10min, and placing the obtained cDNA on ice for standby or preserving at-20 ℃.
The obtained cDNA is further used for miRNA qPCR reaction, and the system is as follows:
miDETECT A TrackTM miRNA Forward Primer 10μM:0.4μL
miDETECT A TrackTM Uni-Reverse Primer 10μM:0.4μL
2×SYBR Green Mix:5μL
cDNA:2μL
RNase-free water:2.2μL
the reaction conditions are as follows: 95 ℃ for 10min;95 ℃ for 5s,60 ℃ for 20s,70 ℃ for 10s,40cycles; dissolution profile: 95℃ 5s,70℃1min,95℃ 15s,1 cycle.
The results show that: 1-7d and the expression levels of miR-1579 and Kr-h1 in each tissue are in negative correlation (see figures 2 c-d), which shows that miR-1579 and Kr-h1 interact in the stem borer.
3) RNA co-immunoprecipitation (RIP) evaluates whether miR-1579 interacts with Kr-h1 in vivo. After 750nL miR-1579 agonist (agomiR-1579, synthesized by Ji Ma company, 200 μm, agomiR modified on the antisense strand, cholesterol modified at the 3' end, two thio-backbone modifications at the 5' end, four thio-backbone modified full-chain methoxy modifications at the 3' end) and agomiR-NC (control) were injected separately into the female pupae, RIP was performed using Ago1 antibodies (Jin Kairui, marchantia). The RIP specifically comprises the following steps: was performed using a Magna RIP kit (Millipore).
A. Tissue pretreatment: grinding the collected fresh female pupa fat bodies of the treatment group and the control group with precooled PBS, centrifuging at 800-1500rcf at 4 ℃ for 5min, discarding the supernatant, and collecting the precipitate;
B. cracking: adding 200-300 mu L of complete RIP (RIP) lysis buffer into the precipitate, blowing and mixing uniformly, carrying out ice lysis for 5min, centrifuging at 14000rcf at 4 ℃ for 15min, and collecting supernatant at-80 ℃ overnight;
C. preparing magnetic beads: reversing the microcentrifuge tube for multiple times to uniformly re-suspend the magnetic beads, placing the magnetic beads in a 1.5mL centrifuge tube, washing the magnetic beads twice by using a RIP washing solution, adding 100 mu L of the RIP washing solution after discarding the washing solution, adding 5 mu g of Ago-1 antibody or normal mouse IgG antibody, performing rotary culture at room temperature for 30min, taking out the short centrifugation, discarding the supernatant, washing the magnetic beads twice, placing the magnetic beads on a magnetic rack, and adding 900 mu L of the RIP immunoprecipitation buffer to form a RIP immunoprecipitation buffer of a magnetic bead-antibody complex;
co-immunoprecipitation of RNA binding protein-RNA complexes: rapidly thawing the lysate obtained in the step B, centrifuging at 14000rcf at 4 ℃ for 10min, taking 100 mu L of supernatant in RIP immunoprecipitation buffer of the magnetic bead-antibody complex, and incubating overnight at 4 ℃;
and E, RNA purification: taking out an immunoprecipitation reaction centrifuge tube, placing the immunoprecipitation reaction centrifuge tube in a magnetic rack, discarding supernatant, washing, discarding washing liquid, adding 150 mu L of proteinase K buffer solution, resuspending, incubating at 55 ℃ for 30min to digest protein, centrifuging briefly after incubation, placing the immunoprecipitation reaction centrifuge tube in the magnetic rack, sucking supernatant in a new centrifuge tube, adding 250 mu L of RIP washing liquid into the new centrifuge tube, and adding 400 mu L of phenol: chloroform: isoamyl alcohol (125:24:1), shaking, centrifuging at 14000rcf at 4 ℃ for 10min, taking the upper phase into a new centrifuge tube, adding 400 mu L of chloroform, shaking, centrifuging at 14000rcf at 4 ℃ for 10min, taking the upper phase into the new centrifuge tube, adding 50 mu L Salt Solution I, 15 mu L Salt Solution II, 5 mu L precipitate Enhancer and 850 mu L of absolute ethanol, and uniformly mixing, and standing overnight at-80 ℃ to precipitate RNA; taking out centrifuge tube, centrifuging at 14000rcf at 4deg.C for 30min, discarding supernatant, washing precipitate with 80% ethanol, centrifuging at 14000rcf at 4deg.C for 10min, discarding supernatant, air drying precipitate, and adding about 20 μl DEPC H 2 O resuspension precipitation to obtain RNA;
F. by PrimeScript TM RT reagent Kit with gDNA Eraser (Perfect Real Time) kit reverse transcribing the RNA obtained in the previous step into cDNA, in a manner consistent with that of examples 1-2-2A, but using PrimeScript TM II 1st Strand cDNA The random hexamers of the random hexamer primers of (Takara) in the Synthesis Kit replaces the RT Primer Mix primers in the Kit; qPCR detects the abundance of Kr-h1, and the qPCR method is identical to the qPCR method in example 1-1, and the primers used in example 1-2-2A for detecting Kr-h1.
The results show that Kr-h1 is significantly enriched after the agomiR-1579 treatment compared to the control (see FIG. 2 e), demonstrating the interaction of miR-1579 with Kr-h1 in vivo.
The above experimental description is summarized: miR-1579 directly targets Kr-h1 and inhibits its expression.
Example 2miR-1579 functional verification
Injecting 350nL miR-1579 agonist (synthesized by agomiR-1579, ji Ma company, 200 mu M) into larvae of 3 days old 2 to overexpress miR-1579, collecting samples for 48 hours, and respectively detecting the expression levels of miR-1579 and Kr-h1, wherein a qPCR detection method is consistent with that of the embodiment 1-2-2A/2B; at the same time, survival rates of 24h, 48h, 72h, 96h and 144h larvae after injection were recorded. The results show that: after the miR-1579 agonist is injected, the expression level of miR-1579 is obviously increased by 113.9 times (see FIG. 3 a), and the expression level of Kr-h1 is reduced by 83.2 percent (see FIG. 3 b), and compared with the death rate of a control (25.9 percent), the death rate of larvae in a treatment group is 91.7 percent (see FIG. 3 c); in addition, dead larvae had smaller and shorter larvae than the control (see fig. 3 d), demonstrating that miR-1579 can act as a potential target for controlling chilo suppressalis.
Example 3 acquisition and screening of MiR-1579-transformed Rice
1. Acquisition of transgenic miR-1579 rice
1) Construction of an artificial miR-1579 expression vector: the expression cassette was constructed from the artificial miRNA expression cassette reported by Jiang et al (2017), in a manner consistent with this example.
2) Genetic transformation of rice: the constructed final expression vector pUbi-amiR-1579 was transformed into well-formed flower 11 by Agrobacterium-mediated transformation. Agrobacterium-mediated genetic transformation essentially comprises the following steps: husking rice seeds and then sterilizing; inducing embryo callus; screening positive rice transformants by using a kanamycin-containing culture medium; somatic embryogenesis; rooting the callus; the fully regenerated plants were transferred to a greenhouse for continued cultivation to obtain T0 generation rice (He et al, 2019).
2. Screening of miR-1579 transformed rice
1) Firstly, extracting genome DNA of 30T 0 generation transgenic rice leaves by adopting a CTAB method, extracting (cool beating, beijing) by using a 2X CTAB extracting solution according to the specification, and then utilizing an hpt gene sequence (hpt-F: ACACTACATGGCGTGATTTCAT (SEQ ID NO: 12); PCR analysis was performed on hpt-R TCCACTATCGGCGAGTACTTCT (SEQ ID NO: 13)) to obtain 30 transgenic rice plants each positive for the transformant (see FIG. 4 a).
2) Digoxin (DIG) label probes using the HPT complement (HPT-F: ACACTACATGGCGTGATTTCAT (SEQ ID NO: 14); HPT-R: TCCACTATCGGCGAGTACTTCT (SEQ ID NO: 15)) to determine the integration and copy number of the genome of transgenic rice, the southern blot experiment was as follows:
A. genomic DNA and plasmid DNA cleavage: the sample was digested with HindIII, genomic DNA 10. Mu.g, 10 XM buffer 3. Mu.L, hindIII 40U, and ddH 2 O to 30 mu L, and enzyme cutting at 37 ℃ for 16h;
B. electrophoresis: preparing 0.8% agarose gel by TAE, and electrophoresis of enzyme digestion products for 16h under 30V voltage;
C. transfer film by capillary method: imprinting the enzyme-digested product after electrophoresis on a nylon membrane by utilizing a capillary method;
D. hybridization and detection: the target fragment in the sample is detected by a non-radioactive detection method, and the result shows that: of the 15 lines, 8 contained one copy of amiR-1579 and the other lines contained multiple copies (see FIG. 4 b).
3) And finally, determining the expression quantity of miR-1579 in each transgenic plant strain by qPCR, so as to select a strain with single copy and high miR-1579 expression for subsequent bioassay experiments. The results show that: since the expression level of 5 lines miR-1579 was high (C# 4, C# 5, C# 10, C# 17, C#22) (FIG. 4C), 3 lines (C# 10, C# 17, C#22) were selected for bioassay.
Example 4 transgenic plant insect-receiving bioassay
The method comprises the following specific steps:
bioassays include indoor bioassays and outdoor bioassays.
(1) Indoor bioassay: cutting the fresh stems of the 3 high miR-1579 expression rice lines obtained in the above way into stem segments, feeding the stem segments to newly hatched 1-year-old larvae, and placing the larvae in a culture dish. Fresh stalks were replaced every 3d until death, and mortality and related parameters were recorded. The results show that: the survival rate of larvae feeding on transgenic amiR-1579 rice was significantly reduced compared to control. The average mortality of the 3 transgenic lines (c# 10, c# 17, c#22) after 30d treatment was 44.4%, 51.1% and 56.7%, respectively. However, the average mortality of the control group was 12.23% (see fig. 5 a), showing a relatively high inhibition of chilo suppressalis. As shown in fig. 5b, larvae fed on transgenic plants showed death and darkened epidermis. The larval survival times were shorter for lines c# 17 and c# 22 compared to the control group, but the differences were not significant (see fig. 5C). Furthermore, the pupae weight of surviving chilo suppressalis was significantly reduced (see FIGS. 5d,5 e).
(2) Outdoor bioassay: since line c# 22 showed more stable and higher resistance in the indoor bioassay, resistance to chilo suppressalis was evaluated using 4-strain jointing booting stage T1 generation transgenes and wild type rice, respectively. Each rice plant is connected with 25 first 1-year larvae, and the larvae are respectively placed in insect-raising cages, and the damage degree of the rice plants is observed. The results show that: after 18d of inoculation, the damage degree of the chilo suppressalis to the transgenic rice is obviously lower than that of the wild rice. Specifically, chilo suppressalis only causes local tissue damage to transgenic rice, but causes extensive damage to wild-type rice (see FIGS. 5g,5h,5i,5 j). In addition, 3 wild-type rice plants died, 1 survived, and 3 survived in 4 transgenic rice plants, with only local tissue damage.
Example 5 safety assessment of transgenic Rice against non-target insects
In order to determine the safety of the transgenic rice against non-target insects, the rice pests Bai Beifei lice Sogatella furcifera (WBPH) in the same ecological niche are used as representative insects, the transgenic rice and the wild rice are fed in the same way, the plant injury condition and the plant hopper mortality rate are observed for each plant of 20 first 1-year nymphs, and relevant parameters are recorded until death. The results show that: the population size, nymph calendar period, cumulative emergence rate and adult life of transgenic miR-1579 rice are not affected (see FIGS. 6 a-e). Meanwhile, the fertility of the long-wing planthoppers fed with the transgenic miR-1579 rice strain is not changed (see figure 6 f). In combination, the miR-1579 rice has no influence on the development and reproduction of the sogatella furcifera, and has stronger specificity.
Example 6 evaluation of agronomic Properties of MiR-1579 transformed Rice
One transgenic rice line (C#10) was selected for evaluation of agronomic traits. Transgenic and wild type rice were grown in the field (FIGS. 7 a-c). From the booting stage to the mature stage, 5 characters of plant height, single plant tillering number, spike length, 500 grain weight and fruiting rate are counted respectively. The seeds were weighed after washing and drying. The results show that: the plant line C# 10 and the wild rice have no obvious difference in plant height (figure 7 d), single plant tillering number (figure 7 e), 500 grain weight (figure 7 f), spike length (figure 7 g) and fruiting rate (figure 7 h), which indicates that the yield of the rice is not affected by transferring miR-1579.
Reference to the literature
Jiang S,Wu H,Liu H,Zheng J,Lin Y,Chen H.2017The overexpression of insect endogenous small RNAs in transgenic rice inhibits growth and delays pupation of striped stem borer(Chilo suppressalis).Pest Manag Sci.73(7),1453-1461.
Chiu J,March PE,Lee R,Tillett D.2004Site-directed,Ligase-Independent Mutagenesis(SLIM):a single-tube methodology approaching 100%efficiency in 4h.Nucleic Acids Res.32(21),e174.
Tang Y,He H,Qu X,Cai Y,Ding W,Qiu L,Li Y.2020RNA interference-mediated knockdown of the transcription factor Krüppel homologue 1suppresses vitellogenesis in Chilo suppressalis.Insect Mol Biol.29(2),183-192.
He K,Xiao H,Sun Y,Ding S,Situ G,Li F.2019Transgenic microRNA-14rice shows high resistance to rice stem borer.Plant Biotechnol J 17(2),461-471。
Claims (10)
1. A miRNA is characterized in that the nucleotide sequence is shown as SEQ ID NO. 1 or the nucleotide sequence shown as SEQ ID NO. 1 is modified, substituted, deleted or added with at least one base to obtain the nucleic acid sequence.
2. A kit, recombinant vector or transgenic cell comprising the miRNA of claim 1.
3. Use of a miRNA according to claim 1 or a kit, recombinant vector or transgenic cell according to claim 2 for insect control, wherein the use is killing of insect bodies.
4. The use according to claim 3, wherein the insect is a rice pest.
5. The use according to claim 4, wherein the rice pest is Chilo suppressalis.
6. Use of a miRNA according to claim 1 or a kit, recombinant vector or transgenic cell according to claim 2 for the preparation of an insecticide.
7. An insecticide containing the miRNA of claim 1 or the kit, recombinant vector or transgenic cell of claim 2.
8. A method of controlling insects, comprising the steps of: expressing the miRNA of claim 1 in a plant.
9. The method of claim 8, wherein the plant is rice.
10. The method according to claim 8, comprising the steps of:
s1, constructing a miRNA expression cassette for mediating gene silencing in vitro by using the miRNA; and transforming the constructed final expression vector into a plant through agrobacterium-mediated transformation to obtain a transgenic plant.
S2, cutting fresh stems of the obtained transgenic plants into stem segments, feeding the stem segments to newly hatched 1-year-old larvae, placing the larvae in a culture dish until death, and recording the death rate and the individual development condition;
or taking a plurality of first 1-year larvae to be connected to the transgenic plants, placing the transgenic plants in an insect-raising cage until death, and recording the death rate and the damage condition of the plants.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310170244.3A CN116376913A (en) | 2023-02-27 | 2023-02-27 | miRNA and application thereof in rice insecticidal improvement |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310170244.3A CN116376913A (en) | 2023-02-27 | 2023-02-27 | miRNA and application thereof in rice insecticidal improvement |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116376913A true CN116376913A (en) | 2023-07-04 |
Family
ID=86962407
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310170244.3A Pending CN116376913A (en) | 2023-02-27 | 2023-02-27 | miRNA and application thereof in rice insecticidal improvement |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116376913A (en) |
-
2023
- 2023-02-27 CN CN202310170244.3A patent/CN116376913A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2018200332B2 (en) | Down-regulating gene expression in insect pests | |
CN106754948B (en) | Nilaparvata lugens NlMLP gene, encoding protein and application thereof | |
CN106414746A (en) | Constructs for expressing transgenes using regulatory elements from brachypodium ubiquitin genes | |
Sun et al. | Inhibition of pds gene expression via the RNA interference approach in Dunaliella salina (Chlorophyta) | |
CN105624188B (en) | A kind of SPL18 gene is improving the application in plant products | |
CN113248586B (en) | Application of brown planthopper PIB14 protein and coding gene thereof in regulation and control of plant brown planthopper resistance | |
CN105087640B (en) | Adjust gene and its application of vegetable seeds development | |
CN116286724B (en) | Lectin receptor protein TaLecRLK2 and encoding gene and application thereof | |
CN106350537A (en) | Method for transforming medicago sativa by aid of galega orientalis gibberellin receptor genes GoGID | |
CN114058618B (en) | Application of glutamate dehydrogenase as target in pest control | |
CN116376913A (en) | miRNA and application thereof in rice insecticidal improvement | |
CN113024645B (en) | Application of wheat transcription factor WRKY70 gene in regulation and control of plant growth and development | |
CN108998454B (en) | Chrysanthemum nankingense aphid resistance-related miRNA160a and application thereof | |
CN105461790B (en) | The application of MYB99 albumen and its encoding gene in regulating and controlling plant seed germination | |
CN104560906B (en) | Specifically expressed protein C YP734A1 like 1 and its application in fibrocyte | |
CN114644702B (en) | Tango protein, related biological material and plant breeding method | |
CN117305266B (en) | Gene OsBDG1 related to rice stress resistance and application of coded protein thereof | |
AU2021107431A4 (en) | Application of Galega orientalis gibberellin receptor gene GoGID1 for improving alfalfa biomass | |
CN117402877B (en) | Application of long-chain non-coding RNA NATAL to regulation of rice yield-related traits | |
CN108949770B (en) | Heliothis armigera E75 gene and application thereof in RNA-mediated pest control | |
KR20180045630A (en) | Novel Gene Related to Plant Drought Stress Tolerance and Use Thereof | |
CN107267553A (en) | A kind of transgenic watermelon new material initiative based on RNAi | |
CN115927316A (en) | Application of miR408 in enhancing plant disease resistance | |
CN116478994A (en) | Application of miR6478 in enhancing plant disease resistance | |
CN117947087A (en) | Protein ZmLHP1 for regulating and controlling corn plant height and responding to high temperature stress and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |